MedTrace Logo

RHODOS Follow-up Single-visit Study

NCT01421381 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-05-27

No results posted yet for this study

Summary

This study aims to evaluate the current visual acuity of SNT-II-003 participants and compare this with the last visit from the SNT-II-003 study.

Conditions

  • Leber's Hereditary Optic Neuropathy

Sponsors & Collaborators

  • Santhera Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Patrick Chinnery, MD · Clinical Research Facility

Eligibility

Min Age
15 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • Canada
  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01421381 on ClinicalTrials.gov